在癌症中区分和治疗抑郁症综合征:一篇综述
Maurizio Fava1, Emily Sorg2, Jamie M Jacobs2
1Department of Psychiatry, Massachusetts General Hospital, Bulfinch 351 - 55 Fruit Street, Boston, MA 02114, United States of America.
General hospital psychiatry
|November 11, 2023
概括
丧气影响高达52%的癌症患者,影响他们的生活质量. 早期评估和治疗对于改善瘤护理结果至关重要.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 心理社会护理 心理社会护理
背景情况:
- 抑郁症在瘤学中很普遍,影响36-52%的患者.
- 它的特点是无法应对,无助,绝望和绝望.
- 丧气与癌症患者的症状负担增加,生活质量降低,睡眠障碍和自杀倾向有关.
研究的目的:
- 突出诊断和评估癌症患者的士气丧失的重要性.
- 从抑郁症中区分士气丧失,强调不同的临床特征.
- 倡导在瘤学中改善抑郁症的诊断和治疗策略.
主要方法:
- 审查现有证据在癌症护理中的 demoralization.
- 诊断标准的分析及其与瘤学的相关性.
- 介绍了临床面试的丧气 (CIDE) 作为一个新的评估工具.
主要成果:
- 丧气综合征与临床抑郁症不同,在癌症患者中表现独特.
- 像DSM-5-TR这样的当前诊断系统可能会忽略丧气,导致诊断不足.
- 抑郁症临床面试 (CIDE) 提供了一种结构化的方法来评估抑郁症的严重程度.
结论:
- 优化丧评估对于有效的干预研究至关重要.
- 对于心情低落的癌症患者,需要特定的诊断标准和经过验证的测量工具.
- 为改善癌症护理的临床和心理社会结果,应对抑郁症至关重要.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Depressive Disorders: MDD and Dysthymia
138
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
138
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


